FDA advisors on Wednesday will deliberate on whether shunt therapy still has a narrow path forward in heart failure after a disappointing pivotal trial. In its premarket approval application for the ...

Patients with heart failure who had a small shunt inserted between the heart's left and right atria did not see any significant benefits overall compared with those who received a placebo procedure ...

Study shows no benefit for heart failure overall but suggests different effects in those with preserved versus reduced ejection fraction Patients with heart failure who had a small shunt inserted ...

Inter-atrial shunts—investigational devices that create a small pathway for blood to pass from the left to the right side of the heart in order to improve heart failure symptoms and outcomes—may be ...

Patients who responded positively to shunt treatment experienced more beneficial changes in their heart's structure and function compared with nonresponders. After 2 years of follow-up, a post hoc ...

Heart failure with preserved ejection fraction (HFpEF) can arise from a range of genetic and physiological triggers, but the common denominator—elevated left atrial (LA) pressure—has spawned a host of ...

Please provide your email address to receive an email when new articles are posted on . Interatrial shunt implant lowered HF hospitalization risk for patients with HFrEF vs. placebo. However, patients ...

For babies born with a certain heart defect, implantation of a "shunt" is essential to their survival. A new type of shunt can be expanded using light after it's been implanted, potentially ...

Doctors say that identifying the right patients will be critical to the future of the field. Only time will tell, according ...